Taragarestrant
Modify Date: 2025-09-21 20:15:09
Taragarestrant structure
|
Common Name | Taragarestrant | ||
|---|---|---|---|---|
| CAS Number | 2118899-51-5 | Molecular Weight | 475.38 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H25Cl2FN2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of TaragarestrantTaragarestrant (D-0502) is a potent, orally active estrogen receptor degrader. Taragarestrant has antiproliferative activity against estrogen receptor-positive breast cancer cell lines and has anticancer activity. Taragarestrant can be used for cancer research[1][2]. |
| Name | Taragarestrant |
|---|
| Description | Taragarestrant (D-0502) is a potent, orally active estrogen receptor degrader. Taragarestrant has antiproliferative activity against estrogen receptor-positive breast cancer cell lines and has anticancer activity. Taragarestrant can be used for cancer research[1][2]. |
|---|---|
| Related Catalog | |
| References |
[2]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical |
| Molecular Formula | C25H25Cl2FN2O2 |
|---|---|
| Molecular Weight | 475.38 |
| InChIKey | PSJRZBBUWGIUPM-BBNFHIFMSA-N |
| SMILES | CC1Cc2c([nH]c3ccccc23)C(c2c(Cl)cc(C=CC(=O)O)cc2Cl)N1CC(C)(C)F |